The drug Vanguard Medical Care’s memory care drug, VMM-150, may not be an approved medication for treating Alzheimer’s disease, but the drugs maker says it’s been used successfully to treat Alzheimer’s.
Vanguard said Monday that the drug’s use was being monitored by a panel of doctors and other researchers in an effort to determine if the drug could treat Alzheimer�s disease.
Vanguard Medical�s VMM.150 Memory Care, which is being used to treat memory loss, is approved by the FDA for Alzheimer�S disease, according to its website.
The drug has been approved in the United States by the National Institute on Aging for treating memory loss in older people.
Vanguard has said it has been able to test the drug against Alzheimer� s disease for the past few years and said the company has found the drug works better than a standard drug that does not block the action of the drug. Vanguard�s memory care product is being tested in people who have had Alzheimer�t disease for at least a year.
The company said that VMM has been used to help people with dementia, Alzheimer�n, and other conditions.
Read more Vanguard Medical has been using the drug to help dementia patients for the last several years.
Vanguard Medical has said that the company�s research team found VMM could be used to improve the quality of life for people with Alzheimer�’s disease.
While Vanguard Medical says its memory care drugs work in Alzheimer�ll disease, it is not known whether those drugs would work to treat the condition in people with other dementia diseases.
A spokesperson for Vanguard Medical said Monday the company does not comment on whether its memory drugs are approved for use in dementia.
The FDA approved Vanguard� s drug, which Vanguard Medical hopes will help reduce the number of people dying from Alzheimer� ll disease.
The FDA said the drug was approved in late March.
FDA approval could be a major step for Vanguard, which has been searching for a new drug that would treat Alzheimer`s disease, which kills about 15,000 Americans each year.
There is no approved drug for Alzheimer’s, and patients with other diseases have to take other medications to control the disease, the Centers for Disease Control and Prevention said in a statement Monday.
People with Alzheimer’s are more likely to have problems controlling their mood and are more prone to mood disorders, depression and anxiety, the CDC said.
Other Alzheimer�ses drugs approved by FDA include a new treatment that helps control the effects of Alzheimer�z disease, a drug that treats Alzheimer�a, and an anti-depressant called mirtazapine.
Dr. James D. Kagan, an expert in Alzheimer’s and director of the University of Pennsylvania�s Institute for Alzheimer Research and Treatment, said a drug approved by regulators to treat dementia could be an important step forward.
He said he hopes more companies will apply to have their drugs tested by regulators.
�I think the FDA has been very successful in its mission of ensuring the safety and effectiveness of drugs for Alzheimerís disease,� Kagan said in an email.
Kagan, who was not involved in the research, said he believes the drug VMM can be used for patients with dementia.
�I think it�s important to start thinking about how to incorporate that into the healthcare industry as well.
I think this drug could be the first of many for that,� he said.